| Dr Ashita Goel, MD | |
|
700 Melvin Ave, Ste 7a, Annapolis, MD 21401-1514 | |
| (410) 280-2260 | |
| Not Available |
| Full Name | Dr Ashita Goel |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 700 Melvin Ave, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023158615 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D0065891 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Company Llc | 4587559026 | 192 |
| Anesthesia Company Llc | 4587559026 | 192 |
News Archive
Data published in The Lancet showed that elderly people with Type 2 Diabetes (T2D) treated for 24 weeks with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, marketed by Boehringer Ingelheim and Eli Lilly and Company, experienced significant reductions in blood glucose levels (HbA1c) compared with those receiving placebo.
The Associated Press examines health insurance costs from different perspectives - that of a small businessman who provides workers with additional compensation to purchase their own coverage, rather than offering a company health plan, and that of a middle-class family facing mounting financial pressure which includes health premiums.
It's possible to postpone the introduction of blood transfusions for an average of 17 months for patients with the low-risk variant of MDS blood cancer, provided they are given erythropoiesis-stimulating agents, which stimulate the body to produce red blood cells, according to a dissertation at Sahlgrenska Academy, Sweden.
A research team at Montefiore Health System and Albert Einstein College of Medicine led by Alain Litwin, M.D., was awarded $14 million by the Patient-Centered Outcomes Research Institute (PCORI) to determine how best to treat hepatitis C among people who inject drugs (PWID), a group with a high rate of infection.
› Verified 7 days ago
| Entity Name | Anesthesia Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871548156 PECOS PAC ID: 4587559026 Enrollment ID: O20040216000401 |
News Archive
Data published in The Lancet showed that elderly people with Type 2 Diabetes (T2D) treated for 24 weeks with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, marketed by Boehringer Ingelheim and Eli Lilly and Company, experienced significant reductions in blood glucose levels (HbA1c) compared with those receiving placebo.
The Associated Press examines health insurance costs from different perspectives - that of a small businessman who provides workers with additional compensation to purchase their own coverage, rather than offering a company health plan, and that of a middle-class family facing mounting financial pressure which includes health premiums.
It's possible to postpone the introduction of blood transfusions for an average of 17 months for patients with the low-risk variant of MDS blood cancer, provided they are given erythropoiesis-stimulating agents, which stimulate the body to produce red blood cells, according to a dissertation at Sahlgrenska Academy, Sweden.
A research team at Montefiore Health System and Albert Einstein College of Medicine led by Alain Litwin, M.D., was awarded $14 million by the Patient-Centered Outcomes Research Institute (PCORI) to determine how best to treat hepatitis C among people who inject drugs (PWID), a group with a high rate of infection.
› Verified 7 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
Data published in The Lancet showed that elderly people with Type 2 Diabetes (T2D) treated for 24 weeks with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, marketed by Boehringer Ingelheim and Eli Lilly and Company, experienced significant reductions in blood glucose levels (HbA1c) compared with those receiving placebo.
The Associated Press examines health insurance costs from different perspectives - that of a small businessman who provides workers with additional compensation to purchase their own coverage, rather than offering a company health plan, and that of a middle-class family facing mounting financial pressure which includes health premiums.
It's possible to postpone the introduction of blood transfusions for an average of 17 months for patients with the low-risk variant of MDS blood cancer, provided they are given erythropoiesis-stimulating agents, which stimulate the body to produce red blood cells, according to a dissertation at Sahlgrenska Academy, Sweden.
A research team at Montefiore Health System and Albert Einstein College of Medicine led by Alain Litwin, M.D., was awarded $14 million by the Patient-Centered Outcomes Research Institute (PCORI) to determine how best to treat hepatitis C among people who inject drugs (PWID), a group with a high rate of infection.
› Verified 7 days ago
| Entity Name | Gbmc Hospital Based Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730824400 PECOS PAC ID: 6002299369 Enrollment ID: O20220818002500 |
News Archive
Data published in The Lancet showed that elderly people with Type 2 Diabetes (T2D) treated for 24 weeks with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, marketed by Boehringer Ingelheim and Eli Lilly and Company, experienced significant reductions in blood glucose levels (HbA1c) compared with those receiving placebo.
The Associated Press examines health insurance costs from different perspectives - that of a small businessman who provides workers with additional compensation to purchase their own coverage, rather than offering a company health plan, and that of a middle-class family facing mounting financial pressure which includes health premiums.
It's possible to postpone the introduction of blood transfusions for an average of 17 months for patients with the low-risk variant of MDS blood cancer, provided they are given erythropoiesis-stimulating agents, which stimulate the body to produce red blood cells, according to a dissertation at Sahlgrenska Academy, Sweden.
A research team at Montefiore Health System and Albert Einstein College of Medicine led by Alain Litwin, M.D., was awarded $14 million by the Patient-Centered Outcomes Research Institute (PCORI) to determine how best to treat hepatitis C among people who inject drugs (PWID), a group with a high rate of infection.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ashita Goel, MD 14545 Edgewoods Way, Glenelg, MD 21737 Ph: (301) 325-6761 | Dr Ashita Goel, MD 700 Melvin Ave, Ste 7a, Annapolis, MD 21401-1514 Ph: (410) 280-2260 |
News Archive
Data published in The Lancet showed that elderly people with Type 2 Diabetes (T2D) treated for 24 weeks with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, marketed by Boehringer Ingelheim and Eli Lilly and Company, experienced significant reductions in blood glucose levels (HbA1c) compared with those receiving placebo.
The Associated Press examines health insurance costs from different perspectives - that of a small businessman who provides workers with additional compensation to purchase their own coverage, rather than offering a company health plan, and that of a middle-class family facing mounting financial pressure which includes health premiums.
It's possible to postpone the introduction of blood transfusions for an average of 17 months for patients with the low-risk variant of MDS blood cancer, provided they are given erythropoiesis-stimulating agents, which stimulate the body to produce red blood cells, according to a dissertation at Sahlgrenska Academy, Sweden.
A research team at Montefiore Health System and Albert Einstein College of Medicine led by Alain Litwin, M.D., was awarded $14 million by the Patient-Centered Outcomes Research Institute (PCORI) to determine how best to treat hepatitis C among people who inject drugs (PWID), a group with a high rate of infection.
› Verified 7 days ago
Dr. Steven H Parker, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Melvin Ave, Suite 7a, Annapolis, MD 21401 Phone: 410-280-2260 | |
Dr. Christine G Cattaneo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Melvin Ave, Suite 7a, Annapolis, MD 21401 Phone: 410-280-2260 | |
Dr. Eileen M Hamill, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 700 Melvin Ave, Suite 7a, Annapolis, MD 21401 Phone: 410-280-2260 | |
Leanne Summers, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Acp 2nd Floor, North Or Desk, Annapolis, MD 21401 Phone: 443-481-1000 | |
Dr. David Anthony Nieglos, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Anne Arundel Medical Center, Annapolis, MD 21401 Phone: 410-280-2260 Fax: 410-280-2290 | |
Richard S. Ro, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 410-280-2260 |